Literature DB >> 28290140

Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer.

Masayuki Akita1, Tetsuo Ajiki2, Taku Matsumoto1, Kenta Shinozaki1, Tadahiro Goto1, Sadaki Asari1, Hirochika Toyama1, Masahiro Kido1, Takumi Fukumoto1, Yonson Ku1.   

Abstract

BACKGROUND: It remains controversial whether preoperative cholangitis affects long-term outcomes after resection in patients with extrahepatic bile duct cancer.
METHODS: A total of 107 patients with extrahepatic bile duct cancer who underwent resection with curative intent from 2008 to 2014 were retrospectively reviewed. Patients were categorized into two groups according to the presence or absence of preoperative cholangitis. Clinicopathological variables and long-term outcomes were compared in the two groups.
RESULTS: In the preoperative cholangitis group, the rate of preoperative biliary drainage, the number of tube changes and/or additions, and the rate of lymph node metastasis were higher compared to the no-cholangitis group. Overall survival and disease-free survival were significantly worse in the cholangitis group compared to the no-cholangitis group (p = 0.022, p = 0.007). A poorer prognosis was not observed with an increasing grade of cholangitis in Tokyo Guidelines 2013 (p = 0.09). A multivariate logistic regression analysis revealed that the preoperative cholangitis was an independent prognostic factor for extrahepatic bile duct cancer.
CONCLUSION: Preoperative cholangitis is an independent prognostic factor in patients with extrahepatic bile duct cancer regardless of the severity of the cholangitis.

Entities:  

Keywords:  Bile duct cancer; Preoperative cholangitis; Prognosis

Mesh:

Year:  2017        PMID: 28290140     DOI: 10.1007/s11605-017-3388-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  32 in total

Review 1.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.

Authors:  Masataka Okuno; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  J Gastroenterol       Date:  2015-07-18       Impact factor: 7.527

3.  The effect of preoperative biliary drainage on infectious complications after hepatobiliary resection with cholangiojejunostomy.

Authors:  Gen Sugawara; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Yu Takahashi; Daisuke Takara; Masato Nagino
Journal:  Surgery       Date:  2012-10-06       Impact factor: 3.982

4.  A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage.

Authors:  Liangru Ke; Yanqun Xiang; Weixiong Xia; Jing Yang; Yahui Yu; Yanfang Ye; Hu Liang; Xiang Guo; Xing Lv
Journal:  Clin Immunol       Date:  2016-01-15       Impact factor: 3.969

5.  Effect of preoperative biliary drainage on surgical results after pancreaticoduodenectomy in patients with distal common bile duct cancer: focused on the rate of decrease in serum bilirubin.

Authors:  Yun Mee Choi; Eung-Ho Cho; Keon-Young Lee; Seung-Ik Ahn; Sun Keun Choi; Sei Joong Kim; Yoon Seok Hur; Young Up Cho; Kee Chun Hong; Seok Hwan Shin; Kyung Rae Kim; Ze-Hong Woo
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

6.  Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.

Authors:  Hai-Jie Hu; Hui Mao; Anuj Shrestha; Yong-Qiong Tan; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Nan-Sheng Cheng; Fu-Yu Li
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

7.  Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Yuichiro Kato; Shinichiro Takahashi; Naoto Gotohda; Masaru Konishi
Journal:  J Gastrointest Surg       Date:  2016-06-01       Impact factor: 3.452

8.  Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma.

Authors:  Jun Sakata; Yoshio Shirai; Yoshiaki Tsuchiya; Toshifumi Wakai; Tatsuya Nomura; Katsuyoshi Hatakeyama
Journal:  Langenbecks Arch Surg       Date:  2009-01-24       Impact factor: 3.445

9.  New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines.

Authors:  Seiki Kiriyama; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Toshihiko Mayumi; Henry A Pitt; Dirk J Gouma; O James Garden; Markus W Büchler; Masamichi Yokoe; Yasutoshi Kimura; Toshio Tsuyuguchi; Takao Itoi; Masahiro Yoshida; Fumihiko Miura; Yuichi Yamashita; Kohji Okamoto; Toshifumi Gabata; Jiro Hata; Ryota Higuchi; John A Windsor; Philippus C Bornman; Sheung-Tat Fan; Harijt Singh; Eduardo de Santibanes; Harumi Gomi; Shinya Kusachi; Atsuhiko Murata; Xiao-Ping Chen; Palepu Jagannath; Sunggyu Lee; Robert Padbury; Miin-Fu Chen
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-09       Impact factor: 7.027

10.  Inflammation and tumor microenvironment in lymph node metastasis.

Authors:  Xuesong Wu; Tomonori Takekoshi; Ashley Sullivan; Sam T Hwang
Journal:  Cancers (Basel)       Date:  2011-03-01       Impact factor: 6.639

View more
  5 in total

1.  Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium.

Authors:  Junya Toyoda; Kota Sahara; Shishir K Maithel; Daniel E Abbott; George A Poultsides; Christopher Wolfgang; Ryan C Fields; Jin He; Charles Scoggins; Kamran Idrees; Perry Shen; Itaru Endo; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2022-06-29       Impact factor: 4.339

2.  Predictors of postoperative early recurrence of extrahepatic bile duct cancer.

Authors:  Masayuki Akita; Tetsuo Ajiki; Kimihiko Ueno; Daisuke Tsugawa; Yu Hashimoto; Motofumi Tanaka; Masahiro Kido; Hirochika Toyama; Takumi Fukumoto
Journal:  Surg Today       Date:  2019-09-23       Impact factor: 2.549

3.  A prognostic nomogram for distal bile duct cancer from Surveillance, Epidemiology, and End Results (SEER) database based on the STROBE compliant.

Authors:  Ye-Yu Zhao; Si-Hai Chen; Qin-Si Wan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 4.  Tackling Surgical Morbidity and Mortality through Modifiable Risk Factors in Cancer Patients.

Authors:  Boram Lee; Ho-Seong Han
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

5.  Inverse Prognostic Relationships of 18F-FDG PET/CT Metabolic Parameters in Patients with Distal Bile Duct Cancer Undergoing Curative Surgery.

Authors:  Hyun Kyung Yi; Yong-Jin Park; Ji Hoon Bae; Jong Kyun Lee; Kwang Hyuk Lee; Seong Ho Choi; Kyung-Han Lee; Byung-Tae Kim; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2018-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.